眼科缝线市场－全球产业规模、份额、趋势、机会、预测：按类型、应用、最终用户、地区和竞争格局划分，2021-2031年

全球眼科缝合线市场预计将从 2025 年的 6.2886 亿美元成长到 2031 年的 9.1501 亿美元，复合年增长率为 6.45%。

这些特製的超细外科缝线对于在涉及眼球及其周围结构的眼部手术中精准进入眼部组织至关重要。市场成长的主要驱动力是全球人口老化加剧，这与青光眼和角膜疾病等需要手术介入的老龄化相关疾病发生率上升密切相关。此外，糖尿病视网膜病变和眼外伤的日益普遍也使得这些特殊伤口缝合装置的需求持续旺盛，以确保患者在术后获得最佳恢復。

市场扩张的一大障碍是无缝合技术的日益普及，例如自闭合切口和生物相容性黏合剂，这些技术正在减少对传统缝合方法的依赖。儘管技术发生了这种转变，但需要治疗的患者数量庞大，这保证了一定的需求水准。根据国际防盲协会（IAPB）2024年的报告，全球约有11亿人患有视力障碍，凸显了对有效眼科手术介入的巨大且持续的需求。

市场驱动因素

全球老年人口的快速成长正成为市场扩张的主要催化剂，这与白内障和青光眼等老龄化眼科疾病的激增直接相关。随着眼部组织老龄化增长而退化，手术干预的需求增加，在自闭合技术不足以应对的复杂手术中，高精度缝合线对于伤口缝合至关重要。这种人口结构的变化推高了医疗耗材的消耗速度，为医疗系统处理等待手术的患者带来了沉重负担。根据英国皇家眼科医师学会2024年5月发布的关于选择性手术目标的报告，英国约有60万名患者正在等待首次眼科医生预约，这凸显了大量手术候选者涌入医疗系统。

同时，角膜移植手术数量的增加推动了专用眼科缝线的消耗，尤其是那些需要特定缝合方式以固定供体角膜片和矫正散光的缝线。与可采用无缝线切口的标准白内障手术不同，角膜移植需要使用细单丝缝线来确保移植片的稳定性并获得良好的屈光效果。根据美国眼库协会2024年3月的统计报告，2023年美国共进行了50,925例角膜移植手术，显示重建手术呈现持续上升趋势。支持这些治疗的商业性规模体现在主要行业参与者的财务表现。例如，爱尔康公司报告称，2023年全年手术产品净销售额达53亿美元，显示眼科手术生态系统具有显着的经济影响力。

市场挑战

无缝线手术技术的日益普及对眼科缝合线市场的商业性成长构成了重大阻碍因素。在现代临床实践中，尤其是在白内障和屈光矫正手术，微创手术的趋势正在加速发展，自闭合切口和生物相容性黏合剂有效地取代了传统的针线缝合。这种转变是由临床需求驱动的，例如最大限度地减少术后散光、减轻发炎和加速患者康復。随着医疗专业人员优先采用这些先进技术来提高手术效率和患者舒适度，标准眼科手术所需的缝合线日常使用量正呈现显着下降趋势。

这种技术变革的影响在以往依赖缝合的高频手术中最为显着，如今这些手术大多采用极少甚至无需缝合。大量手术转向这些替代缝合方法，大大缩小了传统缝合产品的市场。根据美国眼科学会 (AAO) 2024 年的数据，美国每年约进行 400 万例白内障手术。在如此庞大数量的手术中，无缝线超音波超音波术 (Phacoemulsification) 已成为主流方法，这清楚地表明，现代技术的进步正在直接限制对传统伤口缝合装置的需求。

市场趋势

缝合针设计和金属加工技术的进步正在重塑市场格局。製造商们正在研发超细缝合针，以在精细的眼科显微手术中保持其结构完整性。这一趋势满足了临床需求，即在穿刺钙化和纤维化组织时，既要最大限度地减少对角膜和巩膜层的损伤，又要确保缝合针具有足够的抗弯曲性。创新製造商正利用先进的热处理技术和不銹钢合金，生产具有卓越延展性和锋利度保持性的针尖，这对于青光眼和视网膜手术中的高精度操作至关重要。例如，2024年10月，Corza Medical推出了其「Onatec」产品线，该产品线采用高度热处理的不銹钢，实现了卓越的抗弯曲性和针尖精度，适用于显微外科手术。

同时，在眼部整形外科领域，无结缝合和特殊缝合技术的应用日益普及，这主要得益于眼周手术对更佳美学效果的需求。外科医生正逐步采用先进的缝合系统，消除可见的结节。这种缝合系统能够均匀分散切口处的张力，从而减少疤痕，同时预防肉芽肿的形成和患者的不适。全球眼睑年轻化手术的激增极大地推动了这项技术的应用，为美容用途的伤口缝合器械创造了巨大的潜在市场。根据国际美容整形外科学会（ISAPS）2024年6月发布的报告，2023年全球眼睑手术数量将超过170万例，比上年增长24%，这印证了眼部整形外科领域的快速发展。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球眼科缝合线市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（天然、合成）
  • 依应用领域（角膜移植手术、白内障手术、玻璃体切除术、切除术术、眼部整形手术等）
  • 依最终使用者（医院、门诊手术中心等）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美眼科缝合线市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲眼科缝合线市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区眼科缝合线市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲眼科缝合线市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲眼科缝合线市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球眼科缝合线市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic Plc
• Accutome Inc.
• Asset Medical Sarl
• Alcon Inc.
• Aurolab
• B Braun Melsungen AG
• DemeTech Corporation
• FCI Ophthalmic Inc.
• Surgical Specialties Corp
• Teleflex Incorporated

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Ophthalmic Sutures Market is projected to expand from USD 628.86 Million in 2025 to USD 915.01 Million by 2031, reflecting a compound annual growth rate (CAGR) of 6.45%. These specialized, ultra-fine surgical threads are essential for approximating ocular tissues with high precision during surgeries involving the eye and its surrounding structures. Market growth is largely propelled by the expanding global geriatric population, which correlates with a higher incidence of age-related conditions such as glaucoma and corneal disorders that necessitate surgical intervention. Additionally, the increasing prevalence of diabetic retinopathy and ocular trauma maintains a fundamental demand for these specific wound closure devices to ensure optimal postoperative recovery.

A major hurdle to market expansion is the growing adoption of sutureless techniques, including self-sealing incisions and biocompatible adhesives, which decrease reliance on traditional closure methods. Despite this technological transition, the massive volume of patients requiring care guarantees a baseline level of demand. As reported by the International Agency for the Prevention of Blindness in 2024, roughly 1.1 billion people worldwide were living with vision loss, underscoring the immense and continuing need for effective ophthalmic surgical interventions.

Market Driver

The rapidly growing global geriatric population acts as a primary catalyst for market expansion, directly linking to a surge in age-related ocular pathologies like cataracts and glaucoma. As ocular tissues degenerate with age, the need for surgical intervention increases, necessitating high-precision sutures for wound closure in complex procedures where self-sealing techniques are inadequate. This demographic shift places significant pressure on healthcare systems to address procedural backlogs, thereby sustaining the consumption rate of medical consumables. According to the Royal College of Ophthalmologists' May 2024 report on elective activity targets, nearly 600,000 patients in England were waiting for an initial ophthalmologist appointment, highlighting the critical volume of surgical candidates entering the care system.

Simultaneously, the increasing volume of corneal transplantation procedures supports the consumption of specialized ophthalmic sutures, particularly due to the reliance on specific suture patterns to secure donor grafts and manage astigmatism. Unlike standard cataract surgeries that may employ sutureless incisions, keratoplasty requires fine monofilament sutures to ensure graft stability and proper refractive outcomes. The Eye Bank Association of America's March 2024 statistical report noted that domestic keratoplasty procedures in the United States rose to 50,925 in 2023, indicating a sustained upward trend in restorative surgeries. The commercial magnitude of the sector supporting these interventions is reflected in the financial results of major industry players; for instance, Alcon reported $5.3 billion in surgical net sales for the full year 2023, demonstrating the substantial economic impact of the ophthalmic surgical ecosystem.

Market Challenge

The rising adoption of sutureless surgical techniques represents a significant restraint on the commercial growth of the ophthalmic sutures market. Modern clinical practices have increasingly shifted toward minimally invasive procedures, especially in cataract and refractive surgeries, where self-sealing incisions and biocompatible glues effectively replace traditional needle-and-thread closures. This transition is driven by the clinical necessity to minimize postoperative astigmatism, reduce inflammation, and accelerate patient rehabilitation. As medical professionals prioritize these advanced methods to improve surgical efficiency and patient comfort, the routine volume of sutures required for standard ocular interventions is experiencing a measurable decline.

The impact of this technological displacement is most severe in high-volume procedures that historically relied on sutures but now largely operate without them. The sheer scale of surgeries migrating to these alternative closure methods significantly reduces the addressable market for conventional threading products. According to the American Academy of Ophthalmology in 2024, surgeons perform approximately 4 million cataract surgeries annually in the United States. The dominance of sutureless phacoemulsification within such a vast number of procedures illustrates how the evolution of modern techniques directly limits the demand for traditional wound closure devices.

Market Trends

Advancements in suture needle geometry and metallurgy are reshaping the market as manufacturers engineer ultra-fine needles capable of maintaining structural integrity during delicate ocular microsurgeries. This trend addresses the clinical need for needles that resist bending when penetrating calcified or fibrotic tissues while minimizing trauma to the corneal or scleral layers. Innovators are increasingly using advanced tempering processes and stainless steel alloys to produce needle tips with superior ductility and sharpness retention, which are essential for high-precision maneuvers in glaucoma and retinal procedures. For example, Corza Medical announced its Onatec portfolio in October 2024, utilizing highly tempered stainless steel to deliver enhanced bending resistance and needle accuracy for microsurgical applications.

concurrently, the oculoplastic segment is seeing a rising adoption of knotless and specialized suture technologies driven by the demand for superior aesthetic outcomes in periorbital surgeries. Surgeons are shifting toward advanced closure systems that eliminate palpable knots, which can cause granulomas or patient discomfort, while ensuring even tension distribution across the incision to reduce scarring. This technological integration is heavily supported by the surging global volume of eyelid rejuvenation procedures, creating a substantial addressable market for cosmetic-focused wound closure devices. According to the International Society of Aesthetic Plastic Surgery's June 2024 report, eyelid surgery recorded over 1.7 million procedures globally in 2023, reflecting a 24% increase from the previous year and underscoring the expanding scale of the oculoplastic sector.

Key Market Players

• Medtronic Plc
• Accutome Inc.
• Asset Medical Sarl
• Alcon Inc.
• Aurolab
• B Braun Melsungen AG
• DemeTech Corporation
• FCI Ophthalmic Inc.
• Surgical Specialties Corp
• Teleflex Incorporated

Report Scope

In this report, the Global Ophthalmic Sutures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ophthalmic Sutures Market, By Type

• Natural
• Synthetic

Ophthalmic Sutures Market, By Application

• Corneal transplantation surgery
• Cataract surgery
• Vitrectomy surgery
• Iridectomy surgery
• Oculoplastic surgery
• Others

Ophthalmic Sutures Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

Ophthalmic Sutures Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ophthalmic Sutures Market.

Available Customizations:

Global Ophthalmic Sutures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ophthalmic Sutures Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Natural, Synthetic)
  • 5.2.2. By Application (Corneal transplantation surgery, Cataract surgery, Vitrectomy surgery, Iridectomy surgery, Oculoplastic surgery, Others)
  • 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Ophthalmic Sutures Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ophthalmic Sutures Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Ophthalmic Sutures Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Ophthalmic Sutures Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Ophthalmic Sutures Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Ophthalmic Sutures Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Ophthalmic Sutures Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Ophthalmic Sutures Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Ophthalmic Sutures Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Ophthalmic Sutures Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Ophthalmic Sutures Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Ophthalmic Sutures Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Ophthalmic Sutures Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Ophthalmic Sutures Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Ophthalmic Sutures Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Ophthalmic Sutures Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Ophthalmic Sutures Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Ophthalmic Sutures Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Ophthalmic Sutures Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Ophthalmic Sutures Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Ophthalmic Sutures Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Ophthalmic Sutures Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Ophthalmic Sutures Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Ophthalmic Sutures Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Ophthalmic Sutures Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Accutome Inc.
• 15.3. Asset Medical Sarl
• 15.4. Alcon Inc.
• 15.5. Aurolab
• 15.6. B Braun Melsungen AG
• 15.7. DemeTech Corporation
• 15.8. FCI Ophthalmic Inc.
• 15.9. Surgical Specialties Corp
• 15.10. Teleflex Incorporated

16. Strategic Recommendations

17. About Us & Disclaimer